Cancer Chemotherapy: Challenges for the Future, Volume 5 : Proceedings of the Fifth Nagoya International Symposium on Cancer Treatment, Nagoya, Japan, October 2-4, 1989, Volume 5
Excerpta Medica, 1990 - Breast - 364 pages
The Fifth Nagoya International Symposium on Cancer Treatment was held during the period of October 2-4, 1989 and was attended by over 400 oncologists. This book is the proceedings of the symposium and consists of 3 sections as outlined hereunder. The first session, Scientific basis for enhancing chemotherapeutic effects, covers the experimental and pharmacological basis of multicombination chemotherapy, the second session Breast cancer, covers mass screening and treatments, while the third session Drug developments, includes reviews of the new, less toxic analogues of cisplatin developed in the USA and Japan. This volume provides not only a comprehensive treatise on the role of cancer chemotherapy, but it should also give a perspective on future developments.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Prognostic factors and evaluation of effect in drug therapy of breast cancer
Adjuvant systemic therapy in breast cancer
20 other sections not shown
5-Fluorouracil adjuvant adjuvant therapy administration advanced breast cancer agents aminoglutethimide analogs anticancer antigen antitumor activity aromatase inhibitors biochemical biological breast cancer Buzdar Cancer Chemotherapy Cancer Res carboplatin carcinoma CBDCA CDDP cell lines chemotherapy cisplatin Clin Oncol clinical trials clones CNDP combination chemotherapy compound Control cyclophosphamide cytotoxic demonstrated developed disease disease-free dose intensity doxorubicin Dr Buzdar Dr Rustum drug resistance effect endocrine therapy enzyme estradiol estrogen evaluated factors fluoropyrimidines folate FUra G-CSF growth hormone human monoclonal antibody increased infusion inhibition interval cancers Japan leucovorin leukemia lung melanoma metastatic mg/kg mice modulation monoclonal antibody Mouridsen myelosuppression Nagoya observed oophorectomy oral pharmacokinetic phase I study plasma postmenopausal preclinical Proc randomized rats receptor recurrence regimen resistant cells response rate Santen schedule screening sensitive shown Table tamoxifen tegafur therapeutic tissue total dose toxicity treated treatment tumor cells vitro women